Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)
1 other identifier
observational
440
1 country
1
Brief Summary
Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2016
CompletedFirst Posted
Study publicly available on registry
June 23, 2016
CompletedStudy Start
First participant enrolled
February 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2022
CompletedNovember 29, 2022
November 1, 2022
5.8 years
June 20, 2016
November 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the sensitivity and specificity of OCTA
The primary objective of this observational study is to evaluate the sensitivity and specificity to diagnose vascular abnormalities with OCTA compared to conventional imaging methods. The main parameter that will be assessed is area of nonperfusion of the retina. The incidence (binary) of nonperfusion areas will be assessed in OCTA and compared to conventional imaging methods such as fluorescein angiography.
2 years
Secondary Outcomes (3)
Evaluation of the intra-and inter-reader reproducibility of the diagnosis of vascular abnormalities using OCTA
2 years
OCTA and Fundus color photographs
2 years
Subgroup analysis
2 years
Study Arms (8)
Diabetic retinopathy
Patients with various degrees of diabetic retinopathy
Retinal detachment
Patients with a history of retinal detachment
Retinal vein occlusion
Patients with a history of retinal vein occlusion
Arterial hypertension
Patients with a history of arterial hypertension
Carotid artery occlusion
Patients with a history of carotid artery occlusion
Age related macular degeneration
Patients with a history of Age related macular degeneration
Macroaneurysms
Patients with a history of retinal macroaneurysms
Central serous chorioretinopathy
Patients with a history of central serous chorioretinopathy
Interventions
Imaging with optical coherence tomography angiography
Eligibility Criteria
Participants with a history of clinically diagnosed retinal diseases, including but not limited to age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, macular macroaneurysma, and diabetic macular edema and healthy individuals undergoing ophthalmic Imaging in Routine clinical practice will be included
You may qualify if:
- Patients from the Department of Ophthalmology, University Hospital Bern requiring conventional imaging for eye disease and willing to sign informed consent Patients of 18 years or older
You may not qualify if:
- Patients not willing or able to sign informed consent Patients younger than 18 years Patients with epilepsy Patients having had photodynamic therapy within the last 48 hours prior to imaging with OCTA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inselspital Bern, Department of Ophthalmology
Bern, 3010, Switzerland
Related Publications (2)
Tian M, Zeng G, Zinkernagel M, Tappeiner C, Wolf S, Munk MR. Assessment of choriocapillaris and choroidal vascular changes in posterior uveitis using swept-source wide-field optical coherence tomography angiography. Br J Ophthalmol. 2024 Feb 21;108(3):386-390. doi: 10.1136/bjo-2022-322209.
PMID: 36627172DERIVEDTian M, Tappeiner C, Zinkernagel MS, Huf W, Wolf S, Munk MR. Evaluation of vascular changes in intermediate uveitis and retinal vasculitis using swept-source wide-field optical coherence tomography angiography. Br J Ophthalmol. 2019 Sep;103(9):1289-1295. doi: 10.1136/bjophthalmol-2018-313078. Epub 2018 Dec 11.
PMID: 30538102DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Martin Zinkernagel, Prof.MD PhD
Inselspital, University Clinic for Ophthalmology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2016
First Posted
June 23, 2016
Study Start
February 13, 2017
Primary Completion
November 25, 2022
Study Completion
November 25, 2022
Last Updated
November 29, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share